You are subscribed to the FormularyWatch.

Formulary

eNewsletter Subscribe

December 19, 2014

Web Version  | Share with a colleague

Facebook Like Twitter Tweet

Today's Headlines

Novel new drugs approved in 2014

FDA's Center for Drug Evaluation and Research (CDER) reports that it has approved 35 novel new drugs in 2014. These 35 drugs include new molecular entities (NMEs) submitted to CDER in new drug applications (NDAs) and new therapeutic biologics submitted in biologics license applications (BLAs). » Check out the novel drug highlights

FDA grants first-ever CLIA waiver of rapid syphilis test

FDA has granted the first-ever CLIA waiver for the Syphilis Health Check test, a rapid screening test for syphilis. » Read more on syphilis screening

Continuing Education

MTM essentials for smoking cessation

This month's CE activity is part of a year-long CPE series, Medication Therapy Management Considerations for Adult Patients with Cardiovascular Disease. From February 2014 through January 2015, pharmacists can earn up to 24 hours of CPE credit with 12 monthly knowledge-based activities from the University of Connecticut School of Pharmacy and Drug Topics.

The goal of this month's activity is to assist pharmacists in providing smoking cessation services for patients interested in quitting smoking..

To read and print the article with TEST QUESTIONS, click here. To proceed to the online exams and earn up to 2 CPE credits, click here to log in with the session code 14DT13-KCE28.


Announcement: Our CE activities have moved to a new learning management system to better serve you. The login to the Online CE Center is https://web2.uconn.edu/pharmacyce/login.php. All current user registration information has been uploaded for your convenience. Current users do not need to register. To review your registration page to ensure the data is up to date or to register, go to https://web2.uconn.edu/pharmacyce/program_register.php. For a full list of courses, go to http://pharmacy.uconn.edu/academics/ce/drug-topics-and-uconn-ce/

EDITOR'S PICK

New screening test predicts risk of future coronary heart disease

FDA has cleared a new screening test for the prediction of future coronary heart disease (CHD) events, such as myocardial infarction. It is cleared for use in all adults who have no history of CHD. » Details

 

RELATED ARTICLES

FDA drug approvals-December 2014

Read more on screening for conditions

RESOURCES

Latest Clinical News

Powered by Modern Medicine Advanstar Medical Communications Group